Hormel Foods to Sell Turkey Business, Reaffirms Guidance
Hormel Foods announced a definitive agreement to sell its whole-bird turkey business to Life-Science Innovations as part of a strategic shift toward more value-added protein offerings. Separately, the company released preliminary first-quarter results, expecting net sales of $3 billion, and reaffirmed its full-year adjusted guidance.
- The sale is part of Hormel's explicit strategy to reduce its holdings in volatile, commodity-driven businesses and concentrate on higher-margin, value-added protein products. - Whole-bird turkey is subject to significant market volatility due to factors like fluctuating feed costs and diseases such as Highly Pathogenic Avian Influenza (HPAI), which has led to millions of birds being culled. - This divestiture does not include the Jennie-O brand name or its value-added products like ground turkey, which remain a strategic focus for Hormel. - The buyer, Life-Science Innovations, is a holding company with deep roots in the turkey industry through its affiliation with Willmar Poultry Company, indicating a strategic fit for the acquired commodity business. - The transaction includes the acquisition of a production facility in Melrose, Minnesota, and a feed mill in Swanville, Minnesota, with LSI assuming supply contracts from third-party growers. - This portfolio shaping move follows other recent strategic transactions by Hormel, including the 2021 acquisition of the Planters snack business for $3.3 billion and the spin-off of its Justin's nut butter brand. - Hormel's foodservice division has been a strong performer, and shifting focus away from commodity retail allows for greater investment in this higher-growth channel. - The company expects the sale to have a minimal impact on its fiscal 2026 financial results, with more details to be provided during its upcoming first-quarter earnings call.
